SCHEMBL4437339

SCHEMBL4437339

O=Cc1ccc2c(c1)CCN(C(=O)C1CCCCC1)C2

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.65
HDAC6 Q9UBN7 6/20 0.65
HDAC1 Q13547 3/20 0.56
ALDH1A1 P00352 3/20 0.48
CYP3A4 P08684 2/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2C19 P33261 1/20 0.45
POLB P06746 2/20 0.44
MAPT P10636 1/20 0.44
HTT P42858 1/20 0.44
KDM4E B2RXH2 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
TSHR P16473 1/20 0.41
ABCB11 O95342 1/20 0.41
LMNA P02545 1/20 0.41
TP53 P04637 1/20 0.41
MAPK1 P28482 1/20 0.41
OPRK1 P41145 1/20 0.41
BLM P54132 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6969813 0.82 KEAP1 (0.68) KEAP1HDAC6HDAC1ALDH1A1CYP3A4
SCHEMBL4431726 0.81 HDAC6 (0.77) KEAP1HDAC6HDAC1ALDH1A1CYP3A4
SCHEMBL6973432 0.80 KEAP1 (0.62) KEAP1HDAC6HDAC1ALDH1A1CYP3A4
SCHEMBL4425666 0.80 KEAP1 (0.65) KEAP1HDAC6HDAC1ALDH1A1CYP3A4
SCHEMBL16634768 0.79 ESR2 (0.44) HDAC6ALDH1A1MAPTTP53SMN1; SMN2
SCHEMBL1264461 0.79 HDAC6 (1.00) KEAP1HDAC6HDAC1ALDH1A1
SCHEMBL1262890 0.79 HDAC6 (1.00) KEAP1HDAC6HDAC1ALDH1A1
SCHEMBL15652274 0.78 NOTUM (0.59) HDAC6ALDH1A1CYP1A2CYP2C19MAPT
SCHEMBL13085444 0.78 KEAP1 (0.91) KEAP1HDAC6ALDH1A1CYP3A4CYP1A2
SCHEMBL1028087 0.77 HDAC6 (0.93) KEAP1HDAC6HDAC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2125741-A1 TETRAHYDROISOQUINOLINE COMPOUNDS AS MODULATORS OF THE HISTAMINE H3 RECEPTOR Janssen Pharmaceutica, N.V. (BE) 2009-12-02 EP disclosed
US-20090099158-A1 TETRAHYDROISOQUINOLINE COMPOUNDS AS MODULATORS OF THE HISTAMINE H3 RECEPTOR JANSSEN PHARMACEUTICA N.V. (BE) 2009-04-16 US disclosed
WO-2008109336-A1 TETRAHYDROISOQUINOLINE COMPOUNDS AS MODULATORS OF THE HISTAMINE H3 RECEPTOR JANSSEN PHARMACEUTICA N.V. (BE) 2008-09-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090099158-A1 TETRAHYDROISOQUINOLINE COMPOUNDS AS MODULATORS OF THE HISTAMINE H3 RECEPTOR HRH3, HRH4, HRH1 KEAP1 909/4885HDAC6 848/4885HDAC1 353/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.